You are here

Pharmaceutical Approval Update: Oncology April 2006

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Dr. Goldenberg reviews cetuximab (Erbitux) combined with radiation therapy for cancer of the head and neck; sunitinib (Sutent) for gastrointestinal stromal tumors (GISTs) and advanced kidney cancer; and sorafenib tosylate (Nexavar) for advanced renal cell carcinoma.